TCL Archive New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB. October 8, 2004
TCL Archive Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds April 27, 2007
TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987
TCL Archive Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate May 14, 1999